Cargando…

Response of the multiple sclerosis community to COVID-19

Detalles Bibliográficos
Autores principales:	Ciccarelli, Olga, Cohen, Jeffrey A, Thompson, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720349/ https://www.ncbi.nlm.nih.gov/pubmed/32924837 http://dx.doi.org/10.1177/1352458520948748

Ejemplares similares

Commentary on the ECTRIMS–EAN guideline for pharmacological treatment of multiple sclerosis
por: Thompson, Alan J.
Publicado: (2018)

Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity
por: Freund, Patrick, et al.
Publicado: (2010)

Advances in brain imaging in multiple sclerosis
por: Cortese, Rosa, et al.
Publicado: (2019)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis
por: Gorgoraptis, Nikos, et al.
Publicado: (2010)

Spatial variability and changes of metabolite concentrations in the cortico‐spinal tract in multiple sclerosis using coronal CSI
por: Tur, Carmen, et al.
Publicado: (2012)

Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis()
por: Eshaghi, Arman, et al.
Publicado: (2014)

Is the central vein sign a useful diagnostic marker for paediatric-onset multiple sclerosis?
por: Abdel-Mannan, Omar, et al.
Publicado: (2022)

Advances in spinal cord imaging in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

High-dimensional detection of imaging response to treatment in multiple sclerosis
por: Kanber, Baris, et al.
Publicado: (2019)

The 2013 clinical course descriptors for multiple sclerosis: A clarification
por: Lublin, Fred D., et al.
Publicado: (2020)

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions
por: Muhlert, Nils, et al.
Publicado: (2014)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

Community Hospital Response to COVID-19 Outbreak
por: Rahman, Nishad Abdul, et al.
Publicado: (2022)

Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis
por: Kanber, Baris, et al.
Publicado: (2019)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
por: Eshaghi, Arman, et al.
Publicado: (2021)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Multiple Sclerosis: From Molecules to Treatment
por: Broadley, Simon A
Publicado: (2013)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

Multiple Sclerosis, Viruses, and New Vaccines
por: Maple, Peter A. C.
Publicado: (2021)

COMMUNITY PARTICIPATION: KEY TO AN IMPROVED COVID-19 RESPONSE
por: Ilesanmi, O.S, et al.
Publicado: (2020)

WITHDRAWN: Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity
por: Kim, Enoch, et al.
Publicado: (2022)

COVID‐19 Vaccine Response in People with Multiple Sclerosis
por: Tallantyre, Emma C., et al.
Publicado: (2021)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2019)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

Author Correction: Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
por: Eshaghi, Arman, et al.
Publicado: (2021)

DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
por: van de Pavert, Steven H P, et al.
Publicado: (2016)

Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria
por: Brownlee, Wallace J, et al.
Publicado: (2015)

Linking immune-mediated damage to neurodegeneration in multiple sclerosis: could network-based MRI help?
por: Groppa, Sergiu, et al.
Publicado: (2021)

Multiple sclerosis management during the COVID-19 pandemic
por: Moss, Brandon P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qh8krv3s5rd52bkn17hvuqardi